Treatment of Neuropathic Sensitization Disorders
OwnerEdward Tak Weiinventor
Life of this patent
Estimating the term…
Abstract
Among others, the present invention provides a method for treating a neuropathic ocular pain disorder in a subject in need thereof, comprising: topically applying a therapeutically effective amount of a 1-di-isopropyl-phosphinoyl-alkane (DIPA) compound onto an ocular surface of the subject for at least one week, wherein the DIPA compound is dissolved in a liquid vehicle which is adapted for focused delivery of the DIPA compound to the ocular surface.
Claims20
A method for treating a neuropathic ocular pain disorder in a subject in need thereof, comprising topically applying a therapeutically effective amount of a 1-di-isopropyl-phosphinoyl-alkane (DIPA) compound onto an ocular surface of the subject for at least one week, wherein the DIPA compound is dissolved in a liquid vehicle and the liquid vehicle is adapted for focused delivery of the DIPA compound to the ocular surface.
A topical medication for treating a neuropathic ocular pain disorder in a subject in need, comprising an aqueous solution containing a therapeutically effective amount of a 1-di-isopropyl-phosphinoyl-alkane (DIPA) compound.
Use of a 1-di-isopropyl-phosphinoyl-alkane (DIPA) compound for manufacturing a medicament for treating a neuropathic ocular pain disorder in a subject in need thereof, wherein the medicament comprises a therapeutically effective amount of the DIPA compound and a liquid vehicle, wherein the liquid vehicle is adapted for focused delivery of the DIPA compound to an ocular surface of the subject.
Dependencies are inferred from the claim text.